Increase in dATP pool in aphidicolin-resistant mutants of mouse FM3A cells. 1979

D Ayusawa, and K Iwata, and T Kozu, and S Ikegami, and T Seno

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003854 Deoxyribonucleotides A purine or pyrimidine base bonded to a DEOXYRIBOSE containing a bond to a phosphate group. Deoxyribonucleotide
D004257 DNA Polymerase II A DNA-dependent DNA polymerase characterized in E. coli and other lower organisms. It may be present in higher organisms and has an intrinsic molecular activity only 5% of that of DNA Polymerase I. This polymerase has 3'-5' exonuclease activity, is effective only on duplex DNA with gaps or single-strand ends of less than 100 nucleotides as template, and is inhibited by sulfhydryl reagents. DNA Polymerase epsilon,DNA-Dependent DNA Polymerase II,DNA Pol II,DNA Dependent DNA Polymerase II
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females

Related Publications

D Ayusawa, and K Iwata, and T Kozu, and S Ikegami, and T Seno
September 1990, Somatic cell and molecular genetics,
D Ayusawa, and K Iwata, and T Kozu, and S Ikegami, and T Seno
October 1982, Mutation research,
D Ayusawa, and K Iwata, and T Kozu, and S Ikegami, and T Seno
December 2010, Bioscience trends,
D Ayusawa, and K Iwata, and T Kozu, and S Ikegami, and T Seno
December 1984, Mutation research,
D Ayusawa, and K Iwata, and T Kozu, and S Ikegami, and T Seno
March 1992, Experimental cell research,
D Ayusawa, and K Iwata, and T Kozu, and S Ikegami, and T Seno
July 1993, European journal of biochemistry,
D Ayusawa, and K Iwata, and T Kozu, and S Ikegami, and T Seno
June 1987, Molecular & general genetics : MGG,
D Ayusawa, and K Iwata, and T Kozu, and S Ikegami, and T Seno
February 1984, Cancer research,
D Ayusawa, and K Iwata, and T Kozu, and S Ikegami, and T Seno
April 1981, Cancer research,
Copied contents to your clipboard!